Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,644
-$555 QoQ
Shares Held
65
-28.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#734
of 844 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $13,571,646 across 27 Diagnostics & Research names. NTRA ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
9,924 | $4,975,496 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
9,367 | $4,960,669 | |
| 3 | DHR |
Danaher Corp /De/
|
5,136 | $978,305 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,276 | $567,981 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
932 | $490,642 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,443 | $404,040 | |
| 7 | ILMN |
Illumina, Inc.
|
1,331 | $234,029 | |
| 8 | WAT |
Waters Corp /De/
|
533 | $199,896 |
All Filings in NTRA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,644 | 65 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,199 | 91 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,967 | 157 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $36,218 | 225 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,477 | 210 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $17,393 | 123 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $16,146 | 102 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,948 | 102 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,937 | 101 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $91 | 1 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $62 | 1 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||